209 related articles for article (PubMed ID: 25024377)
1. The differential regulation of human ACT1 isoforms by Hsp90 in IL-17 signaling.
Wu L; Wang C; Boisson B; Misra S; Rayman P; Finke JH; Puel A; Casanova JL; Li X
J Immunol; 2014 Aug; 193(4):1590-9. PubMed ID: 25024377
[TBL] [Abstract][Full Text] [Related]
2. The psoriasis-associated D10N variant of the adaptor Act1 with impaired regulation by the molecular chaperone hsp90.
Wang C; Wu L; Bulek K; Martin BN; Zepp JA; Kang Z; Liu C; Herjan T; Misra S; Carman JA; Gao J; Dongre A; Han S; Bunting KD; Ko JS; Xiao H; Kuchroo VK; Ouyang W; Li X
Nat Immunol; 2013 Jan; 14(1):72-81. PubMed ID: 23202271
[TBL] [Abstract][Full Text] [Related]
3. Neutrophil Extracellular Traps Induce Human Th17 Cells: Effect of Psoriasis-Associated TRAF3IP2 Genotype.
Lambert S; Hambro CA; Johnston A; Stuart PE; Tsoi LC; Nair RP; Elder JT
J Invest Dermatol; 2019 Jun; 139(6):1245-1253. PubMed ID: 30528823
[TBL] [Abstract][Full Text] [Related]
4. An ACT1 mutation selectively abolishes interleukin-17 responses in humans with chronic mucocutaneous candidiasis.
Boisson B; Wang C; Pedergnana V; Wu L; Cypowyj S; Rybojad M; Belkadi A; Picard C; Abel L; Fieschi C; Puel A; Li X; Casanova JL
Immunity; 2013 Oct; 39(4):676-86. PubMed ID: 24120361
[TBL] [Abstract][Full Text] [Related]
5. CIKS/Act1-mediated signaling by IL-17 cytokines in context: implications for how a CIKS gene variant may predispose to psoriasis.
Sønder SU; Paun A; Ha HL; Johnson PF; Siebenlist U
J Immunol; 2012 Jun; 188(12):5906-14. PubMed ID: 22581863
[TBL] [Abstract][Full Text] [Related]
6. The Act1 D10N missense variant impairs CD40 signaling in human B-cells.
Yu N; Lambert S; Bornstein J; Nair RP; Enerbäck C; Elder JT
Genes Immun; 2019 Jan; 20(1):23-31. PubMed ID: 29302052
[TBL] [Abstract][Full Text] [Related]
7. ACT1 Is Required for Murine IL-23-Induced Psoriasiform Inflammation Potentially Independent of E3 Ligase Activity.
Lipovsky A; Slivka PF; Su Z; Wang Y; Paulsboe S; Wetter J; Namovic MT; Gauvin D; Perron D; Gauld SB; McGaraughty S; Goedken ER
J Invest Dermatol; 2021 Jul; 141(7):1772-1779.e6. PubMed ID: 33548244
[TBL] [Abstract][Full Text] [Related]
8. Persistent stimulation with interleukin-17 desensitizes cells through SCFβ-TrCP-mediated degradation of Act1.
Shi P; Zhu S; Lin Y; Liu Y; Liu Y; Chen Z; Shi Y; Qian Y
Sci Signal; 2011 Nov; 4(197):ra73. PubMed ID: 22045853
[TBL] [Abstract][Full Text] [Related]
9. New insight into the functions of the interleukin-17 receptor adaptor protein Act1 in psoriatic arthritis.
Doyle MS; Collins ES; FitzGerald OM; Pennington SR
Arthritis Res Ther; 2012 Oct; 14(5):226. PubMed ID: 23116200
[TBL] [Abstract][Full Text] [Related]
10. Act1, a U-box E3 ubiquitin ligase for IL-17 signaling.
Liu C; Qian W; Qian Y; Giltiay NV; Lu Y; Swaidani S; Misra S; Deng L; Chen ZJ; Li X
Sci Signal; 2009 Oct; 2(92):ra63. PubMed ID: 19825828
[TBL] [Abstract][Full Text] [Related]
11. A Novel Nuclear Function for the Interleukin-17 Signaling Adaptor Protein Act1.
Velichko S; Zhou X; Zhu L; Anderson JD; Wu R; Chen Y
PLoS One; 2016; 11(10):e0163323. PubMed ID: 27723765
[TBL] [Abstract][Full Text] [Related]
12. The adaptor Act1 is required for interleukin 17-dependent signaling associated with autoimmune and inflammatory disease.
Qian Y; Liu C; Hartupee J; Altuntas CZ; Gulen MF; Jane-Wit D; Xiao J; Lu Y; Giltiay N; Liu J; Kordula T; Zhang QW; Vallance B; Swaidani S; Aronica M; Tuohy VK; Hamilton T; Li X
Nat Immunol; 2007 Mar; 8(3):247-56. PubMed ID: 17277779
[TBL] [Abstract][Full Text] [Related]
13. IL-17 induced NOTCH1 activation in oligodendrocyte progenitor cells enhances proliferation and inflammatory gene expression.
Wang C; Zhang CJ; Martin BN; Bulek K; Kang Z; Zhao J; Bian G; Carman JA; Gao J; Dongre A; Xue H; Miller SD; Qian Y; Hambardzumyan D; Hamilton T; Ransohoff RM; Li X
Nat Commun; 2017 May; 8():15508. PubMed ID: 28561022
[TBL] [Abstract][Full Text] [Related]
14. A CC' loop decoy peptide blocks the interaction between Act1 and IL-17RA to attenuate IL-17- and IL-25-induced inflammation.
Liu C; Swaidani S; Qian W; Kang Z; Sun P; Han Y; Wang C; Gulen MF; Yin W; Zhang C; Fox PL; Aronica M; Hamilton TA; Misra S; Deng J; Li X
Sci Signal; 2011 Nov; 4(197):ra72. PubMed ID: 22045852
[TBL] [Abstract][Full Text] [Related]
15. Dual Role of Act1 in Keratinocyte Differentiation and Host Defense: TRAF3IP2 Silencing Alters Keratinocyte Differentiation and Inhibits IL-17 Responses.
Lambert S; Swindell WR; Tsoi LC; Stoll SW; Elder JT
J Invest Dermatol; 2017 Jul; 137(7):1501-1511. PubMed ID: 28274739
[TBL] [Abstract][Full Text] [Related]
16. Targeting interleukin-22 in psoriasis.
Hao JQ
Inflammation; 2014 Feb; 37(1):94-9. PubMed ID: 23978911
[TBL] [Abstract][Full Text] [Related]
17. The inducible kinase IKKi is required for IL-17-dependent signaling associated with neutrophilia and pulmonary inflammation.
Bulek K; Liu C; Swaidani S; Wang L; Page RC; Gulen MF; Herjan T; Abbadi A; Qian W; Sun D; Lauer M; Hascall V; Misra S; Chance MR; Aronica M; Hamilton T; Li X
Nat Immunol; 2011 Aug; 12(9):844-52. PubMed ID: 21822257
[TBL] [Abstract][Full Text] [Related]
18. Treatment with IL-17 prolongs the half-life of chemokine CXCL1 mRNA via the adaptor TRAF5 and the splicing-regulatory factor SF2 (ASF).
Sun D; Novotny M; Bulek K; Liu C; Li X; Hamilton T
Nat Immunol; 2011 Aug; 12(9):853-60. PubMed ID: 21822258
[TBL] [Abstract][Full Text] [Related]
19. Identification of a Long Noncoding RNA
He R; Wu S; Gao R; Chen J; Peng Q; Hu H; Zhu L; Du Y; Sun W; Ma X; Zhang H; Cui Z; Wang H; Martin BN; Wang Y; Zhang CJ; Wang C
J Immunol; 2021 May; 206(10):2353-2365. PubMed ID: 33941656
[TBL] [Abstract][Full Text] [Related]
20. Psoriasis and other Th17-mediated skin diseases.
Tokura Y; Mori T; Hino R
J UOEH; 2010 Dec; 32(4):317-28. PubMed ID: 21226422
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
